Intervals survival time. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Cell Line, Tumor Cells, Cultured Bile Ducts, Intrahepatic Spleen Tumor Cells, Cultured Brain Cell Line Lymph Nodes Lung Liver

Organisms10

Mice, Inbred C57BL Mice, Inbred BALB C Mice, Nude Mice, Knockout Mice, Inbred Strains Dogs Mice, Transgenic Mice, SCID Rats, Sprague-Dawley Mice, Inbred DBA

Diseases55

Lung Neoplasms Adenocarcinoma Neoplasm Recurrence, Local Brain Neoplasms Liver Neoplasms Disease Progression Breast Neoplasms Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Stomach Neoplasms Carcinoma, Hepatocellular Glioblastoma Pancreatic Neoplasms Carcinoma, Squamous Cell Lymphatic Metastasis Disease Models, Animal Recurrence Ovarian Neoplasms Carcinoma Glioma Neoplasms Melanoma Esophageal Neoplasms Neoplasm Invasiveness Carcinoma, Small Cell Bile Duct Neoplasms Cholangiocarcinoma Kidney Neoplasms Supratentorial Neoplasms Bone Neoplasms Prostatic Neoplasms Postoperative Complications Pleural Neoplasms Dog Diseases Carcinoma, Renal Cell Mesothelioma Neoplasms, Experimental Leukemia L1210 Colonic Neoplasms Skin Neoplasms Peritoneal Neoplasms Multiple Myeloma Genetic Predisposition to Disease Acute Disease Rectal Neoplasms Astrocytoma Lymphoma Neutropenia Lymphoma, Non-Hodgkin Kidney Failure, Chronic Head and Neck Neoplasms Osteosarcoma Body Weight Sarcoma

Chemicals and Drugs44

Antineoplastic Agents Cisplatin Tumor Markers, Biological Fluorouracil Deoxycytidine Doxorubicin Cyclophosphamide Antimetabolites, Antineoplastic Paclitaxel Vincristine Etoposide Leucovorin Antibodies, Monoclonal Nimustine Carboplatin Organoplatinum Compounds Antineoplastic Agents, Phytogenic Dacarbazine Taxoids Camptothecin Prednisone Vinblastine Antineoplastic Agents, Alkylating Immunosuppressive Agents Methotrexate RNA, Messenger Antibodies, Monoclonal, Humanized Tegafur Neoplasm Proteins Oxonic Acid Oxyquinoline Drug Combinations Recombinant Proteins Tumor Suppressor Protein p53 Vindesine Biological Markers Cytarabine Proto-Oncogene Proteins Ki-67 Antigen Antibiotics, Antineoplastic Epirubicin Survival of Motor Neuron 1 Protein Mitomycin Receptor, erbB-2

Analytical, Diagnostic and Therapeutic Techniques and Equipment102

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Prognosis Retrospective Studies Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Proportional Hazards Models Neoplasm Staging Combined Modality Therapy Confidence Intervals Risk Factors Prospective Studies Multivariate Analysis Cohort Studies Drug Administration Schedule Immunohistochemistry Risk Assessment Predictive Value of Tests Incidence Case-Control Studies Disease Models, Animal Chemotherapy, Adjuvant Registries Transplantation, Homologous Odds Ratio Palliative Care Neoplasm Transplantation Infusions, Intravenous Analysis of Variance Remission Induction Regression Analysis Logistic Models Chi-Square Distribution Probability Skin Transplantation Risk Radiotherapy, Adjuvant Radiotherapy Dosage Randomized Controlled Trials as Topic Life Tables Actuarial Analysis Heart Transplantation Cause of Death Severity of Illness Index Liver Transplantation Chemoembolization, Therapeutic Reverse Transcriptase Polymerase Chain Reaction Salvage Therapy Administration, Oral Clinical Trials as Topic Treatment Failure Reproducibility of Results Models, Statistical Random Allocation Drug Therapy, Combination Neoplasm Grading Radiotherapy Tumor Burden Electrocardiography Statistics, Nonparametric Neoplasms, Experimental Gene Expression Profiling Kidney Transplantation Hepatectomy Blotting, Western Dose Fractionation Models, Biological SEER Program Neoadjuvant Therapy Xenograft Model Antitumor Assays Karnofsky Performance Status Sensitivity and Specificity Transplantation, Heterologous Cranial Irradiation Chemoradiotherapy Prevalence Longitudinal Studies Corneal Transplantation Immunotherapy Clinical Trials, Phase III as Topic Gastrectomy Tomography, X-Ray Computed Injections, Intraperitoneal Tissue Array Analysis Patient Selection Life Expectancy Reoperation Immunoenzyme Techniques Lethal Dose 50 Reference Values Double-Blind Method Biostatistics Infusions, Intra-Arterial Oligonucleotide Array Sequence Analysis Polymerase Chain Reaction Mortality Injections, Intravenous Body Weight Dose-Response Relationship, Radiation

Psychiatry and Psychology1

Phenomena and Processes28

Cell Survival Time Factors Graft Survival Apoptosis Dose-Response Relationship, Drug Odds Ratio Graft Rejection Signal Transduction Cell Proliferation Gene Expression Regulation, Neoplastic Mutation Chi-Square Distribution Probability Genotype Risk Pregnancy Drug Resistance, Neoplasm Longevity Phenotype Sensitivity and Specificity Genetic Predisposition to Disease Cell Division Polymorphism, Single Nucleotide Lethal Dose 50 Body Weight Dose-Response Relationship, Radiation Cell Death Gene Expression

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena4

Survival Birth Intervals Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science9

Survival Rate Incidence Registries Life Tables Cause of Death SEER Program Prevalence Life Expectancy Mortality

Named Groups3

Infant, Newborn Survivors European Continental Ancestry Group

Health Care53

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Retrospective Studies Kaplan-Meier Estimate Follow-Up Studies Proportional Hazards Models Confidence Intervals Risk Factors Prospective Studies Multivariate Analysis Cohort Studies Age Factors Risk Assessment Predictive Value of Tests Incidence Case-Control Studies Registries Odds Ratio Palliative Care Analysis of Variance Regression Analysis Logistic Models Chi-Square Distribution Probability Risk Sex Factors Birth Intervals Randomized Controlled Trials as Topic Life Tables Actuarial Analysis Cause of Death Severity of Illness Index Clinical Trials as Topic Treatment Failure Reproducibility of Results Models, Statistical Random Allocation Statistics, Nonparametric SEER Program Karnofsky Performance Status Sensitivity and Specificity Prevalence Longitudinal Studies Age Distribution Clinical Trials, Phase III as Topic Patient Selection Life Expectancy Double-Blind Method Comorbidity Mortality Dose-Response Relationship, Radiation

Geographicals3

United States Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Survival Rate Cell Survival Survival Analysis Disease-Free Survival Survival Treatment Outcome Time Factors Graft Survival Prognosis Retrospective Studies Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Proportional Hazards Models Neoplasm Staging Lung Neoplasms Combined Modality Therapy Confidence Intervals Risk Factors Prospective Studies Multivariate Analysis Antineoplastic Agents Cisplatin Adenocarcinoma Cohort Studies Neoplasm Recurrence, Local Brain Neoplasms Liver Neoplasms Disease Progression Drug Administration Schedule Breast Neoplasms Tumor Markers, Biological Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Fluorouracil Immunohistochemistry Age Factors Apoptosis Colorectal Neoplasms Risk Assessment Predictive Value of Tests Cell Line, Tumor Stomach Neoplasms Deoxycytidine Incidence Mice, Inbred C57BL Carcinoma, Hepatocellular Doxorubicin Cyclophosphamide Glioblastoma Pancreatic Neoplasms Carcinoma, Squamous Cell Case-Control Studies Lymphatic Metastasis Mice, Inbred BALB C Disease Models, Animal Chemotherapy, Adjuvant Dose-Response Relationship, Drug Recurrence Antimetabolites, Antineoplastic Ovarian Neoplasms Registries Transplantation, Homologous Odds Ratio Carcinoma Graft Rejection Glioma Paclitaxel Neoplasms Palliative Care Neoplasm Transplantation Infusions, Intravenous Vincristine Analysis of Variance United States Signal Transduction Remission Induction Regression Analysis Cell Proliferation Melanoma Etoposide Gene Expression Regulation, Neoplastic Logistic Models Esophageal Neoplasms Neoplasm Invasiveness Carcinoma, Small Cell Mutation Leucovorin Bile Duct Neoplasms Antibodies, Monoclonal Nimustine Carboplatin Chi-Square Distribution Probability Skin Transplantation Genotype Risk Sex Factors Birth Intervals Radiotherapy, Adjuvant

No FAQ available that match "intervals survival time"